Apogee Therapeutics, LLC

The biopharmaceutical industry has been through a tremendous period of company creation, and even with a drop in financings during 2022 and 2023 from record levels of funding in 2020 and 2021, the las

Rising Leaders Home Waltham, MA-based Apogee Therapeutics, LLC launched at the end of 2022 as a spin-out from Paragon Therapeutics, with $169m funding and a handful of inflammation and immunology (

Included for 2024 are investors, CEOs of small and mid-sized companies, rising employees in larger businesses, as well as individuals driving unique health initiatives worldwide. The 30 people below h

Viking Therapeutics ’ share price soared in Q1 as generalist investors continued their landgrab of biopharma companies developing novel obesity therapies. That put it top of the share price gainers am